Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1Jingnan Zhang, Lili Ji, Zhenlin Huang et al.|Acta Pharmaceutica Sinica B|2023Cited by 33
A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitisQian Guo, Ling Yang|Theranostics|2023Cited by 24